← FDA Drug Approvals (Drugs@FDA)
SELEXIPAG
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN LABORATORIES PRIVATE LTD · Approved 2026-01-16
Drug application
- FDA Application #
ANDA214367- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SELEXIPAG
- Generic name
- Selexipag
- Active ingredients
- SELEXIPAG
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- MSN LABORATORIES PRIVATE LTD
- First approval
- 2026-01-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown